impaxlabs.com
Our Experience | Impax Laboratories, Inc.
http://www.impaxlabs.com/our_experience
Experience Is Our Strength. At Impax Laboratories we have created a strong platform for growth built on a broad base of drug delivery expertise, formulation technology and experience in product development. Impax Generics Division has a wealth of experience and a track record of product approvals. Investing in our people is a key ingredient to our success and a benefit in building a strong organization. Within our Generics Division:. 21 products pending at the FDA. 21 products under development. RYTARY (...
impaxlabs.com
Specialty Pharma | Impax Laboratories, Inc.
http://www.impaxlabs.com/our_divisions/specialty_pharma
Our Specialty Pharma Division is a neurology-focused, specialty pharmaceutical company, dedicated to developing products for unmet needs in the treatment of Central Nervous System (CNS) disorders. Experience in Neurology Research. In February 2012, we licensed from AstraZeneca the exclusive U.S. commercial rights to Zomig (zolmitriptan) tablet, orally disintegrating tablet, and nasal spray formulations pursuant to the terms of the AZ Agreement and began sales of the Zomig products under our label...Zomig...
impaxlabs.com
Products and Pipeline | Impax Laboratories, Inc.
http://www.impaxlabs.com/our_experience/products_and_pipeline
An Expanding Product Portfolio. Impax’s ongoing strategy to invest in R&D and to develop high-value opportunities should continue to provide the potential for growth in the future. Within our Specialty Pharma Division, we market:. Learn more about our Generics Division. Learn more about our Specialty Pharma Division. We currently have 21 pending Abbreviated New Drug Applications (ANDA) at the FDA. We are also working on an additional 21 products under development with many having the potential to be ...
rytaryhcp.com
Clinical Trial Results - RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules
http://rytaryhcp.com/clinical-trial-results
And tags, as close as possible to the opening tag. Var axel = Math.random() " " ;. Var a = axel * 10000000000000;. Document.write(' );. YOU ARE NOW LEAVING RYTARYHCP.COM. Impax Specialty Pharma, a division of Impax Laboratories, Inc., does not review the. Information contained on the following website for content, accuracy, or completeness. Use of and access to the information are subject to the terms, limitations, and. Laboratories, Inc., makes no claims about the accuracy or any other aspect of the.
impaxpharma.com
Products | Impax Pharmaceuticals
http://www.impaxpharma.com/products
Impax Pharmaceuticals: Commercialization and Sales. Committed to improving patient lives through advancing knowledge of treatments for neurological disorders. Since inception in July 2006, Impax Pharmaceuticals commercial organization has established a leading presence within the neurology community. Impax deploys approximately 77 field personnel determined to further enhance and solidify long standing relationships with over 8,500 neurologists in the US. In February 2012, we licensed from AstraZeneca th...
rytaryhcp.com
Patient Assistance Program – RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules
http://rytaryhcp.com/patient-resources/assistance-program
YOU ARE NOW LEAVING RYTARYHCP.COM. Impax Specialty Pharma, a division of Impax Laboratories, Inc., does not review the. Information contained on the following website for content, accuracy, or completeness. Use of and access to the information are subject to the terms, limitations, and. Conditions set by the website producer. Impax Specialty Pharma, a division of Impax. Laboratories, Inc., makes no claims about the accuracy or any other aspect of the. Impax Laboratories, Inc., endorse the website. RYTARY...
rytaryhcp.com
Dosing Charts – RYTARY™ (Carbidopa and Levodopa) Extended Release Capsules
http://rytaryhcp.com/professional-resources/interactive-dosing-charts
YOU ARE NOW LEAVING RYTARYHCP.COM. Impax Specialty Pharma, a division of Impax Laboratories, Inc., does not review the. Information contained on the following website for content, accuracy, or completeness. Use of and access to the information are subject to the terms, limitations, and. Conditions set by the website producer. Impax Specialty Pharma, a division of Impax. Laboratories, Inc., makes no claims about the accuracy or any other aspect of the. Impax Laboratories, Inc., endorse the website. Maximu...
rytaryhcp.com
Starting Patients - RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules
http://rytaryhcp.com/dosing/starting-patients
YOU ARE NOW LEAVING RYTARYHCP.COM. Impax Specialty Pharma, a division of Impax Laboratories, Inc., does not review the. Information contained on the following website for content, accuracy, or completeness. Use of and access to the information are subject to the terms, limitations, and. Conditions set by the website producer. Impax Specialty Pharma, a division of Impax. Laboratories, Inc., makes no claims about the accuracy or any other aspect of the. Impax Laboratories, Inc., endorse the website. Are in...